Invitae Partners with BridgeBio Pharma to Harness Genetic In

SAN FRANCISCO, Jan. 30, 2024 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced a partnership with BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company focused

Related Keywords

W Michael Korn , Sun Gou Ji , Renee Kelley , Linkedin Invitae , Invitae Corporation , Twitter , Nasdaq , Bio Pharma Inc , Facebook , Exchange Commission , Instagram , Bridgebio Pharma , Private Securities Litigation Reform Act , Quarterly Report , Region ,